LISA STUBBS: Open Payments
NPI 1427222827 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 50 payments from 19 companies in 2025. Trend: 2023 $813 · 2024 $853 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $285 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Novo Nordisk Inc | 4 | $69 |
| Tris Pharma Inc | 3 | $64 |
| Corcept Therapeutics | 2 | $45 |
| Neuronetics, Inc. | 1 | $30 |
| Organon LLC | 2 | $28 |
| Boston Scientific Corporation | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: QULIPTA, VRAYLAR, Auvelity, Dyanavel XR, Korlym, Wegovy, NEUROSTAR TMS THERAPY SYSTEM, JARDIANCE.
Industry payments across UT — which companies pay providers there.
